STAT+: Senate Democrats push back on the notion that adding dental, vision to Medicare would bankrupt it
Key Senate Democrats used a hearing Wednesday to push back on the argument that expanding…
Category: Congress
Elizabeth Warren on over-the-counter hearing aids, health lobbying, and the FDA’s independence
WASHINGTON — On Tuesday the Food and Drug Administration took a major step toward allowing…
Opinion: Investing in caregiving: a social, public health, and economic issue
As a working daughter, I recently embarked on a new and uncertain phase of my…
STAT+: Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs
Phoenix, Ariz. is no Kendall Square. Its biotech companies, ventures like OncoMyx Therapeutics and VisionGate,…
STAT+: Amazon is beefing up its health care lobbying operation
WASHINGTON — Amazon is bulking up its efforts to influence health care policy at the…
Politics is derailing a crucial debate over the immunity you get from recovering from Covid-19
WASHINGTON — Among scientists, there’s little debate: People who get sick with Covid-19 develop at…
.jpg)
Opinion: In the calm before the superbug storm, the world needs to prepare
Failing to plan, it’s been said, is planning to fail. By this standard, the United…
STAT+: Is Robert Califf a savvy choice to helm the FDA — again?
WASHINGTON — The Food and Drug Administration has been without a permanent leader for 10…
Francis Collins’ resignation could complicate the fight over funding for ARPA-H
WASHINGTON — Francis Collins’ announcement last week that he will soon step down as National…
STAT+: Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
WASHINGTON — A key Senate panel is seriously considering a new policy that would soften…
STAT+: Big business lobbies bitterly divided over drug pricing reform
WASHINGTON — Groups representing companies like Apple, Tesla, and Boeing are clashing with Washington’s wealthiest…
STAT+: In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking
WASHINGTON — Ten House Democrats fired a warning shot in the spring that they could…
STAT+: Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: U.S. lawmakers accuse patent office of weakening patent challenges and allowing drug prices to rise
A bipartisan group of lawmakers has accused the U.S. Patent & Trademark Office of “weakening”…
STAT+: Senate proposes expanding pharma penalties for hiking drug prices
WASHINGTON — A key Senate panel is expanding its plans to punish drug makers that…
STAT+: ‘A solid black eye’: Drug pricing reform advocates scramble to reset after setback in Congress
WASHINGTON — For the cadre of progressive groups fighting to bring down drug prices in…
Opinion: President Biden: Don’t misuse Bayh-Dole march-in rights
In a misguided attempt to control drug costs, some Congressional leaders are urging the Biden…
STAT+: Drug makers failed to block House provision cracking down on orphan drug tax credits
WASHINGTON — Drug makers mounted a last-minute, and so far unsuccessful, campaign to kill a surprise…
Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote
WASHINGTON — House Speaker Nancy Pelosi’s aggressive drug pricing package failed a key committee vote…
Opinion: Congress is about to legislate a future without new medicines. We have a better plan
One of the fundamental principles on which the U.S. economy is based is that the…
STAT+: Key senator opposes Democrats’ target for drug-pricing savings
WASHINGTON — An influential Senate Democrat is pushing back against his party’s efforts to cut…
House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain
WASHINGTON — Three moderate House Democrats are making good on their threat to oppose Speaker…
STAT+: Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates
WASHINGTON — Senate lawmakers are actively considering pegging the prices Medicare pays for drugs to…
Congress is ready to dig into drug prices
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
.jpg)
Opinion: To lower drug costs, define ‘cost’ to mean net cost after rebates
In what could be a turning point in the prescription drug debate, President Biden has…
STAT+: Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
WASHINGTON — As Democrats design a way to use the government’s leverage to lower drug…
Congress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug
WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related…
STAT+: The 10 power players to watch on Democrats’ drug pricing push
WASHINGTON — In the coming weeks, Democrats will embark on an ambitious effort to change…
Opinion: Cannabis legalization must address medical use, not just recreational use
Legislation to legalize cannabis at the federal level recently proposed by Sen. Chuck Schumer (D-N.Y.)…
STAT+: Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices
WASHINGTON — Five of the most vulnerable Democrats in the Senate on Tuesday publicly renewed…
Desperate for relief amid Covid-19, hospitals find an unusual ally in Susan Collins
WASHINGTON — The lobbying frenzy began late last month, as senators and the White House…
Billions in new research funding sparks a lobbying frenzy among patient advocates
WASHINGTON — President Biden’s vision for an ambitious new government research center is never quite…
STAT+: Congress presses the FDA to move faster on ALS drugs
WASHINGTON — Lawmakers pressed a top Food and Drug Administration official Thursday for answers on…
STAT+: Hospitals and pharma are both on the hook to help fund infrastructure deal
WASHINGTON — Both hospitals and drug makers are on the hook to help pay for…
What happened to the FDA’s toughest regulator?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Listen: Breakthrough infections, the power of lobbying, & pharma’s cinematic villainy
Did we take off our masks too soon? Can Democrats pass a drug pricing bill?…
STAT+: San Francisco, Austin, or Raleigh? White House contemplates an out-of-D.C. address for new biomedical research agency
WASHINGTON — The White House isn’t worried about Congress underfunding the new biomedical research agency…
STAT+: Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill
WASHINGTON — The very next day after Rep. Scott Peters attempted to torpedo House Speaker…
STAT+: Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal
WASHINGTON — Senate Democrats intend to include several drug pricing policies in their $3.5 trillion…
Biden wants a drug pricing plan in 45 days. Who’s going to write it?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Powerful House Democrats demand documents from Biogen about coordination with FDA on new Alzheimer’s drug
WASHINGTON — Two powerful House Democrats on Monday demanded documents from Biogen about the approval…
STAT+: In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August
WASHINGTON — President Biden on Friday will take aim at the pharmaceutical industry by ordering…
STAT+: House Democrats say pharma stock buybacks and dividends exceed R&D spending
A Congressional committee released a report on Thursday showing the 14 largest drug makers spent…
Opinion: Uterine fibroids affect millions of women. Why has this condition been overlooked for decades?
In 2007, the late Rep. Stephanie Tubbs Jones (D-Ohio) wrote an op-ed calling for passage…
Are pharma mergers bad for biotech?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Washington’s antitrust push could limit Amazon, Google’s health care ambitions
WASHINGTON — Washington is abuzz with an ambitious new antitrust effort to rein in the…
Operation Warp Speed — now, the ‘CAG’— is here to stay
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
Opinion: Biden won’t end cancer — or any other disease — by importing drug price controls from Europe
In his first budget, President Biden set aggressive health goals. “Let’s end cancer as we…
STAT+: House leaders to investigate FDA approval and price of Biogen’s Alzheimer’s drug
WASHINGTON — The top House Democrats on two powerful committees on Friday announced an investigation…
Opinion: The PASTEUR Act can help win the war against superbugs
Look no further than the coronavirus pandemic to see an immediate and high-profile example of…